Hogan Lovells Publications
13 December 2018
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.
Hogan Lovells Publications
12 December 2018
Last week the Food and Drug Administration (FDA) issued a proposed set of new regulations to further define and update the De Novo review process. Although De Novo review has been available ...
Hogan Lovells Publications
11 December 2018
Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.
Hogan Lovells Publications
11 December 2018
On 11 December 2018, the Dutch Senate approved draft legislation introducing the Netherlands Commercial Court (NCC). The aim of the legislation is to introduce a flexible, efficient and...
Hogan Lovells Publications
11 December 2018
On December 6, the Food and Drug Administration (FDA) published a framework for its Real-World Evidence (RWE) Program to strategically leverage information gathered from real-world...
Hogan Lovells Publications
10 December 2018
Hogan Lovells Publications
10 December 2018
Class actions have become an increasingly common means to seek redress in data privacy cases. With data breaches and data privacy claims on the rise, we asked our lawyers in France and the...
Hogan Lovells Publications
10 December 2018
Weekly newsletter on employment matters.
